Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 19: 731-736, 1973;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turner, A. K.
Right arrow Articles by Chattoraj, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turner, A. K.
Right arrow Articles by Chattoraj, S. C.

Clinical Chemistry, Vol 19, 731-736, Copyright © 1973 by the American Association for Clinical Chemistry

Simultaneous Competitive Protein Binding Assay for Cortisol, Cortisone, and Prednisolone in Plasma, and Its Clinical Application

Adrian K. Turner 1, Carthage J. Carroll 1, Jack L. Pinkus 1, David Charles 1, and Sati C. Chattoraj 1

1 Department of Obstetrics and Gynecology, Boston University School of Medicine, 80 East Concord St., Boston, Mass. 02118.

Simultaneous measurement of cortisol, cortisone, and prednisolone is described. A dichloromethane extract of plasma is separated and purified by partition thin-layer chromatography and assayed by competitive protein binding. Using 0.2 ml of plasma, we could assay about 1 µg of these three steroids per 100 ml. We measured plasma corticosteroids in men on prednisone therapy, during ACTH stimulation, and in pregnant women at the time of delivery, and also in arterial and venous blood samples collected from the umbilical cord. Plasma concentrations of prednisolone (4.46 ± 1.07 µg/100 ml) were maximal 2 h after oral administration of prednisone (10 mg). Basal concentrations of cortisol and cortisone in these subjects were 10.50 ± 1.04 and 1.88 ± 0.69 (SD) µg/100 ml, respectively. The values decreased to less than 1 µg/100 ml 4 h after administration and returned to 12.82 ± 1.92 and 2.16 ± 0.49 µg/100 ml, respectively, by 24 h. After intramuscular injection of synthetic ACTH, values for cortisol and cortisone were maximal at 30 min, declining to pre-injection concentrations within 4 h. Plasma cortisol and cortisone values for maternal venous blood at delivery were 47.0 ± 8.5 and 7.1 ± 2.2, umbilical vein blood 4.9 ± 2.6 and 19.7 ± 2.8 and in blood from the umbilical arteries 7.3 ± 4.5 and 11.6 ± 4.9 µg/ 100 ml, respectively. Cortisol was higher (P < 0.05) in the umbilical arteries, cortisone (P < 0.01) in the umbilical vein.


Key Words: thin-layer chromatography • effects of ACTH • pregnancy • prednisone therapy • values for umbilical cord blood • corticosteroid-binding globulin

Submitted on March 19, 1973
Accepted on April 26, 1973







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1973 by the American Association for Clinical Chemistry.